Air pollution associated with increased risk of stroke, anxiety
the ONA take:
According to two studies published in The British Medical Journal today, researchers have found that air pollution is linked to a higher risk of stroke and anxiety.
In the first study, researchers from the University of Edinburgh in Scotland performed a systematic review and meta analysis to evaluate the association between short term air pollution exposure and hospital admission and deaths related to stroke in 28 countries.
Results showed that there was an association between carbon monoxide, sulfur dioxide, and nitrogen dioxide and stroke-related hospital admissions or death.
Particularly, the first day of air pollution exposure and low- to middle-income countries were found to have the strongest association.
The second study conducted by researchers at the John Hopkins University in Baltimore, Maryland, and Harvard University in Cambridge, Massachusetts, investigated the association between air pollution and anxiety. Results of that study showed 15% of the 71,271 women aged 57 to 85 years studied experienced high anxiety symptoms.
Researchers found that women who lives 50 to 200 meters from a major road were more likely to have higher anxiety symptoms compared with those who lived greater than 200 meters away. Researchers did not observe an association in those living within 50 meters of a major road.
Air pollution is linked to a higher risk of stroke and anxiety.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|